We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
11 similar At Market Issuance Sales Agreement contracts by Novavax Inc, American Superconductor Corp /De/, Anworth Mortgage Asset Corp, others
SOLIGENIX, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • August 11th, 2017 • Soligenix, Inc. • Pharmaceutical preparations • New York
Standard Contracts
MONMOUTH REAL ESTATE INVESTMENT CORPORATION (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • June 29th, 2017 • Monmouth Real Estate Investment Corp • Real estate investment trusts • New York
PLUG POWER INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 3rd, 2017 • Plug Power Inc • Electrical industrial apparatus • New York
Plug Power Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) as follows:
AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • February 27th, 2017 • Novavax Inc • Biological products, (no disgnostic substances) • New York
VIEWRAY, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 30th, 2017 • ViewRay, Inc. • Electromedical & electrotherapeutic apparatus • New York
ViewRay, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) as follows:
AMERICAN SUPERCONDUCTOR CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 27th, 2017 • American Superconductor Corp /De/ • Motors & generators • New York
American Superconductor Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with FBR Capital Markets & Co. (“FBR”), as follows:
AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • December 30th, 2016 • Novavax Inc • Biological products, (no disgnostic substances) • New York
Novavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co., a Delaware limited liability company (“FBR”), as follows:
ENPHASE ENERGY, INC. Common Stock (par value $0.00001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • December 23rd, 2016 • Enphase Energy, Inc. • Semiconductors & related devices • New York
Enphase Energy, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”), as follows:
BIONDVAX PHARMACEUTICALS LTD. American Depositary Shares (each representing 40 fully paid Ordinary Shares) AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • November 4th, 2016 • BiondVax Pharmaceuticals Ltd. • Biological products, (no disgnostic substances) • New York
ANWORTH MORTGAGE ASSET CORPORATION Common Stock (par value $0.01 per share) (par value $0.01 per share) (par value $0.01 per share) AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • August 10th, 2016 • Anworth Mortgage Asset Corp • Real estate investment trusts • New York
ANWORTH MORTGAGE ASSET CORPORATION, a Maryland corporation (the “Company”), and ANWORTH MANAGEMENT LLC, a Delaware limited liability company (the “Manager”), confirm their agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”), as follows:
MANNKIND CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 26th, 2016 • Mannkind Corp • Pharmaceutical preparations • New York
MannKind Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”), as follows: